Detection of significant prostate cancer using target saturation in transperineal MRI/ TRUS-fusion biopsy by S. Tschirdewahn, M. Wiesenfarth, D. Bonekamp, L. Püllen, H. Reis, A. Panic, C. Kesch, C. Darr, F. Giganti, M. Forsting, A. Wetter, B. Hadaschik, J.P. Radtke

Get full text

The value of PSA density in PI-RADS 3 lesions on multiparametric MRI - a strategy to avoid unnecessary prostate biopsies by M. Görtz, J.P. Radtke, G. Hatiboglu, V. Schütz, G. Tosev, M. Güttlein, J. Leichsenring, A. Stenzinger, D. Bonekamp, H. Schlemmer, M. Hohenfellner, J.N. Nyarangi-Dix

Get full text

Five-year outcomes from a prospective phase I study of MRI-guided transurethral ultrasound ablation in men with localized prostate cancer by J. Chin, G. Hatiboglu, S.M. Nair, J. Relle, J. Hafron, M.C. Roethke, M.B. Mueller-Wolf, D. Bonekamp, Z. Kassam, R. Staruch, M. Burtnyk, H. Schlemmer, S. Pahernik

Get full text

Pivotal trial of MRI-guided transurethral ultrasound ablation in men with localized prostate cancer: Two-year follow-up by L.H. Klotz, J. Chin, G. Hatiboglu, M. Koch, D. Penson, C. Pavlovich, S. Raman, A. Oto, J. Fütterer, J. Relle, Y. Lotan, A. Heidenreich, M. Serrallach, M. Haider, D. Bonekamp, T. Tirkes, S. Arora, A. Pantuck, G. Zagaja, M. Sedelaar, K. Macura, D. Costa, T. Persigehl, S. Eggener

Get full text

Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer – Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase I... by C.A. Fink, J. Ristau, C. Buchele, S. Klüter, J. Liermann, P. Hoegen-Saßmannshausen, E. Sandrini, A. Lentz-Hommertgen, L. Baumann, N. Andratschke, M. Baumgartl, M. Li, M. Reiner, S. Corradini, J. Hörner-Rieber, D. Bonekamp, H.-P. Schlemmer, C. Belka, M. Guckenberger, J. Debus, S.A. Koerber

Get full text